Combined Modality Treatment of Resectable and Borderline Resectable Pancreas Cancer: Expert Consensus Statement
Gespeichert in:
| Veröffentlicht in: | Annals of surgical oncology 2009-07, Vol.16 (7), p.1751-1756 |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1756 |
|---|---|
| container_issue | 7 |
| container_start_page | 1751 |
| container_title | Annals of surgical oncology |
| container_volume | 16 |
| creator | Abrams, Ross A. Lowy, Andrew M. O’Reilly, Eileen M. Wolff, Robert A. Picozzi, Vincent J. Pisters, Peter W. T. |
| description | |
| doi_str_mv | 10.1245/s10434-009-0413-9 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67374796</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>67374796</sourcerecordid><originalsourceid>FETCH-LOGICAL-c435t-67ab548c6f68917a715befdcfb80527223acc42c7c8ea4f7798a9a88d22751433</originalsourceid><addsrcrecordid>eNp1kU1r3DAQhkVpaZJNf0AvRfTQm1N9WlJvjclHISEhSc9Clsdlgy1tJBmafx8tu5BQ6EmD5nnfGeZF6DMlJ5QJ-T1TIrhoCDENEZQ35h06pLL-iFbT97UmrW4Ma-UBOsr5kRCqOJEf0QE13BBDyCGKXZz7dYABX8fBTevyjB8SuDJDKDiO-A4y-OL6CbALAz6NaYA0VcHbzq0Lvooy7moB6Qc--7uBVHAXQ4aQl4zviyuw9TxGH0Y3Zfi0f1fo9_nZQ3fZXN1c_Op-XjVecFmaVrleCu3bsdWGKqeo7GEc_NhrIplijDvvBfPKa3BiVMpoZ5zWA2NKUsH5Cn3b-W5SfFogFzuvs4dpcgHikm2ruBLKtBX8-g_4GJcU6m62enEpdb3sCtEd5FPMOcFoN2k9u_RsKbHbKOwuClujsNsorKmaL3vjpZ9heFXsb18BtgNybYU_kF4n_9_1BUqalEI</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>227355841</pqid></control><display><type>article</type><title>Combined Modality Treatment of Resectable and Borderline Resectable Pancreas Cancer: Expert Consensus Statement</title><source>MEDLINE</source><source>SpringerLink Journals</source><creator>Abrams, Ross A. ; Lowy, Andrew M. ; O’Reilly, Eileen M. ; Wolff, Robert A. ; Picozzi, Vincent J. ; Pisters, Peter W. T.</creator><creatorcontrib>Abrams, Ross A. ; Lowy, Andrew M. ; O’Reilly, Eileen M. ; Wolff, Robert A. ; Picozzi, Vincent J. ; Pisters, Peter W. T.</creatorcontrib><identifier>ISSN: 1068-9265</identifier><identifier>EISSN: 1534-4681</identifier><identifier>DOI: 10.1245/s10434-009-0413-9</identifier><identifier>PMID: 19390900</identifier><language>eng</language><publisher>New York: Springer-Verlag</publisher><subject>Antineoplastic Agents - administration & dosage ; Chemotherapy, Adjuvant ; Clinical Trials as Topic ; Combined Modality Therapy ; Consensus Report: Resectable and Borderline Resectable Pancreas Cancer ; Humans ; Medicine ; Medicine & Public Health ; Neoadjuvant Therapy ; Oncology ; Pancreatic Neoplasms - diagnosis ; Pancreatic Neoplasms - surgery ; Pancreatic Neoplasms - therapy ; Radiotherapy, Adjuvant ; Research Design ; Surgery ; Surgical Oncology</subject><ispartof>Annals of surgical oncology, 2009-07, Vol.16 (7), p.1751-1756</ispartof><rights>Society of Surgical Oncology 2009</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c435t-67ab548c6f68917a715befdcfb80527223acc42c7c8ea4f7798a9a88d22751433</citedby><cites>FETCH-LOGICAL-c435t-67ab548c6f68917a715befdcfb80527223acc42c7c8ea4f7798a9a88d22751433</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1245/s10434-009-0413-9$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1245/s10434-009-0413-9$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>309,310,314,776,780,785,786,23909,23910,25118,27901,27902,41464,42533,51294</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19390900$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Abrams, Ross A.</creatorcontrib><creatorcontrib>Lowy, Andrew M.</creatorcontrib><creatorcontrib>O’Reilly, Eileen M.</creatorcontrib><creatorcontrib>Wolff, Robert A.</creatorcontrib><creatorcontrib>Picozzi, Vincent J.</creatorcontrib><creatorcontrib>Pisters, Peter W. T.</creatorcontrib><title>Combined Modality Treatment of Resectable and Borderline Resectable Pancreas Cancer: Expert Consensus Statement</title><title>Annals of surgical oncology</title><addtitle>Ann Surg Oncol</addtitle><addtitle>Ann Surg Oncol</addtitle><subject>Antineoplastic Agents - administration & dosage</subject><subject>Chemotherapy, Adjuvant</subject><subject>Clinical Trials as Topic</subject><subject>Combined Modality Therapy</subject><subject>Consensus Report: Resectable and Borderline Resectable Pancreas Cancer</subject><subject>Humans</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Neoadjuvant Therapy</subject><subject>Oncology</subject><subject>Pancreatic Neoplasms - diagnosis</subject><subject>Pancreatic Neoplasms - surgery</subject><subject>Pancreatic Neoplasms - therapy</subject><subject>Radiotherapy, Adjuvant</subject><subject>Research Design</subject><subject>Surgery</subject><subject>Surgical Oncology</subject><issn>1068-9265</issn><issn>1534-4681</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNp1kU1r3DAQhkVpaZJNf0AvRfTQm1N9WlJvjclHISEhSc9Clsdlgy1tJBmafx8tu5BQ6EmD5nnfGeZF6DMlJ5QJ-T1TIrhoCDENEZQ35h06pLL-iFbT97UmrW4Ma-UBOsr5kRCqOJEf0QE13BBDyCGKXZz7dYABX8fBTevyjB8SuDJDKDiO-A4y-OL6CbALAz6NaYA0VcHbzq0Lvooy7moB6Qc--7uBVHAXQ4aQl4zviyuw9TxGH0Y3Zfi0f1fo9_nZQ3fZXN1c_Op-XjVecFmaVrleCu3bsdWGKqeo7GEc_NhrIplijDvvBfPKa3BiVMpoZ5zWA2NKUsH5Cn3b-W5SfFogFzuvs4dpcgHikm2ruBLKtBX8-g_4GJcU6m62enEpdb3sCtEd5FPMOcFoN2k9u_RsKbHbKOwuClujsNsorKmaL3vjpZ9heFXsb18BtgNybYU_kF4n_9_1BUqalEI</recordid><startdate>20090701</startdate><enddate>20090701</enddate><creator>Abrams, Ross A.</creator><creator>Lowy, Andrew M.</creator><creator>O’Reilly, Eileen M.</creator><creator>Wolff, Robert A.</creator><creator>Picozzi, Vincent J.</creator><creator>Pisters, Peter W. T.</creator><general>Springer-Verlag</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TO</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope></search><sort><creationdate>20090701</creationdate><title>Combined Modality Treatment of Resectable and Borderline Resectable Pancreas Cancer: Expert Consensus Statement</title><author>Abrams, Ross A. ; Lowy, Andrew M. ; O’Reilly, Eileen M. ; Wolff, Robert A. ; Picozzi, Vincent J. ; Pisters, Peter W. T.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c435t-67ab548c6f68917a715befdcfb80527223acc42c7c8ea4f7798a9a88d22751433</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Antineoplastic Agents - administration & dosage</topic><topic>Chemotherapy, Adjuvant</topic><topic>Clinical Trials as Topic</topic><topic>Combined Modality Therapy</topic><topic>Consensus Report: Resectable and Borderline Resectable Pancreas Cancer</topic><topic>Humans</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Neoadjuvant Therapy</topic><topic>Oncology</topic><topic>Pancreatic Neoplasms - diagnosis</topic><topic>Pancreatic Neoplasms - surgery</topic><topic>Pancreatic Neoplasms - therapy</topic><topic>Radiotherapy, Adjuvant</topic><topic>Research Design</topic><topic>Surgery</topic><topic>Surgical Oncology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Abrams, Ross A.</creatorcontrib><creatorcontrib>Lowy, Andrew M.</creatorcontrib><creatorcontrib>O’Reilly, Eileen M.</creatorcontrib><creatorcontrib>Wolff, Robert A.</creatorcontrib><creatorcontrib>Picozzi, Vincent J.</creatorcontrib><creatorcontrib>Pisters, Peter W. T.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><jtitle>Annals of surgical oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Abrams, Ross A.</au><au>Lowy, Andrew M.</au><au>O’Reilly, Eileen M.</au><au>Wolff, Robert A.</au><au>Picozzi, Vincent J.</au><au>Pisters, Peter W. T.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Combined Modality Treatment of Resectable and Borderline Resectable Pancreas Cancer: Expert Consensus Statement</atitle><jtitle>Annals of surgical oncology</jtitle><stitle>Ann Surg Oncol</stitle><addtitle>Ann Surg Oncol</addtitle><date>2009-07-01</date><risdate>2009</risdate><volume>16</volume><issue>7</issue><spage>1751</spage><epage>1756</epage><pages>1751-1756</pages><issn>1068-9265</issn><eissn>1534-4681</eissn><cop>New York</cop><pub>Springer-Verlag</pub><pmid>19390900</pmid><doi>10.1245/s10434-009-0413-9</doi><tpages>6</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1068-9265 |
| ispartof | Annals of surgical oncology, 2009-07, Vol.16 (7), p.1751-1756 |
| issn | 1068-9265 1534-4681 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_67374796 |
| source | MEDLINE; SpringerLink Journals |
| subjects | Antineoplastic Agents - administration & dosage Chemotherapy, Adjuvant Clinical Trials as Topic Combined Modality Therapy Consensus Report: Resectable and Borderline Resectable Pancreas Cancer Humans Medicine Medicine & Public Health Neoadjuvant Therapy Oncology Pancreatic Neoplasms - diagnosis Pancreatic Neoplasms - surgery Pancreatic Neoplasms - therapy Radiotherapy, Adjuvant Research Design Surgery Surgical Oncology |
| title | Combined Modality Treatment of Resectable and Borderline Resectable Pancreas Cancer: Expert Consensus Statement |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-11T08%3A21%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Combined%20Modality%20Treatment%20of%20Resectable%20and%20Borderline%20Resectable%20Pancreas%20Cancer:%20Expert%20Consensus%20Statement&rft.jtitle=Annals%20of%20surgical%20oncology&rft.au=Abrams,%20Ross%20A.&rft.date=2009-07-01&rft.volume=16&rft.issue=7&rft.spage=1751&rft.epage=1756&rft.pages=1751-1756&rft.issn=1068-9265&rft.eissn=1534-4681&rft_id=info:doi/10.1245/s10434-009-0413-9&rft_dat=%3Cproquest_cross%3E67374796%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=227355841&rft_id=info:pmid/19390900&rfr_iscdi=true |